5866-97-7 Usage
General Description
2,6-Dichloro-3-nitrobenzaldehyde, also known as Dichlone, is a chemical compound that is commonly used in organic synthesis and as an intermediate in the production of various pharmaceuticals and agrochemicals. It is a pale yellow crystalline solid with a strong odor and is not soluble in water. 2,6-Dichloro-3-nitrobenzaldehyde has a variety of applications, including as a reagent in the preparation of diverse chemical compounds, such as dyes and fluorescent brighteners. It is also used as a precursor in the synthesis of pharmaceuticals and as an intermediate in the manufacturing of herbicides and insecticides. Additionally, it has been studied for its potential use in the treatment of cancer and other diseases due to its unique chemical properties.
Check Digit Verification of cas no
The CAS Registry Mumber 5866-97-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,8,6 and 6 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 5866-97:
(6*5)+(5*8)+(4*6)+(3*6)+(2*9)+(1*7)=137
137 % 10 = 7
So 5866-97-7 is a valid CAS Registry Number.
InChI:InChI=1/C7H3Cl2NO3/c8-5-1-2-6(10(12)13)7(9)4(5)3-11/h1-3H
5866-97-7Relevant articles and documents
INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
-
Page/Page column 18; 19, (2021/04/17)
Compounds and pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth.
INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
-
Page/Page column 12-13, (2021/09/11)
A compound of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth: (I)
INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
-
Page/Page column 17-18, (2021/10/22)
A pharmaceutical composition comprising the compound of Formula Ia, Formula Ib, Formula Ic, or Formula Id, or a pharmaceutically acceptable salt thereof, is set forth. (Formula Ia), (Formula Ib), (Formula Ic), (Formula Id)
